News

UPDATE Effective January 25 2018, Tharawat Holdings and HCi Viocare, have mutually decided that the formation of the JV that was agreed between them in July 2017, is no longer viewed as a strategic priority and have therfore terminated the Joint Venture Agreement between them. The management of HCi Viocare intents to re-evaluate this decision from... more
In April 2017 HCI Viocare's wholly owned UK based subsidiary, HCI Viocare Technologies Ltd. participated in a prestigious and collaborative research grant proposal along with the Imperial College of London and Ossur Inc. (the no. 2 manufacturer of prosthetic and orthotic devices in the world, with an annual sales of $521 million USD) as well as... more
Today we have started shipping our 4 th Generation Athletic Smart insoles to the sports shoes manufacturers with whom we are in discussions. The 4th Generation Smart insole is the closest to commercial-ready product due to its significantly higher level of durability and resolution , as well as its improved communication and connectivity... more
We are a granted participant of the 10th International Conference on Advanced Technologies & Treatments for Diabetes(ATTD) , this week in Paris . The Company has been recognized for its contribution to the development of innovative solutions in the diabetes prevention and treatment fields and has won a grant for its participation at the... more

Pages